Is Astrana Health (ASTH) Undervalued Following Its Verda Healthcare Partnership?
How Investors May Respond To Astrana Health (ASTH) Expanding Culturally Tailored Care In Underserved U.S. Communities
Astrana Health (ASTH) Stock Could Look Fully Priced On New Multi State Partnership
Verda Healthcare, Inc. and AstranaCare Partners Form a Multi-State Partnership
Astrana Health, Inc. Schedules 2026 Third Quarter Financial Results Release and Conference Call
Why Astrana Health, Inc. (ASTH) is Poised to Beat Earnings Estimates Again
Astrana Health (ASTH): Buy, Sell, or Hold Post Q2 Earnings?
Healthcare Technology for Providers Stocks Q2 In Review: Astrana Health (NASDAQ:ASTH) Vs Peers
Why Astrana Health (ASTH) Shares Are Trading Lower Today
Astrana Health Affirms FY2026 Sales Guidance of $3.800B-$4.100B vs $4.004B Est
Astrana Health Says Cybersecurity Incident Is Material After Unauthorized Data Access, Does Not Expect Material Financial Impact
Watching Astrana Health; Glass House Research Issues Report On Co Stating It Holds A Short Position
Oppenheimer Initiates Coverage On Astrana Health with Outperform Rating, Announces Price Target of $53
5 Must-Read Analyst Questions From Astrana Health’s Q2 Earnings Call
Astrana Health (ASTH) Q2 2026 Earnings Call Transcript
Astrana Health: 81% Full-Risk And Profitable
Truist Securities Maintains Buy on Astrana Health, Raises Price Target to $55
ASTH Q2 Deep Dive: AI-Driven Operating Leverage and Strategic Expansion Shape Outlook
Astrana Health (ASTH) Stock Sees Modest Fair Value Lift As Analysts Back Integration Progress
Barclays Maintains Overweight on Astrana Health, Raises Price Target to $53
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.